Kurz gefasst
Fachartikel in der Zeitschrift Maghreb - Machrek, 2025. Verfasst von Philippe Adair und 2 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kidney involvement in ANCA vasculitides (AAV) is common and often severe, leading to end-stage kidney disease either immediately, during follow-up, or after relapse episodes. Kidney involvement is associated with involvement of other organs in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), but it may also be isolated in cases of vasculitis limited to the kidney. It is less common in eosinophilic granulomatosis with polyangiitis (EGPA). The classical clinical presentation is one of rapidly progressive glomerulonephritis, associated with the presence of PR3-ANCA or MPO-ANCA. Renal biopsy (showing pauci-immune extracapillary glomerulonephritis) is not essential for the diagnosis of AAV, but it has prognostic value, helps to eliminate alternative diagnoses (particularly in isolated renal forms), and can guide the decision to perform plasma exchange. Treatment of AAV with kidney involvement is based on a combination of corticosteroids and immunosuppressants (rituximab or cyclophosphamide). Avacopan may also be proposed as a cortisone-sparing treatment. This review sets out the various recommended therapeutic protocols and their scope of application. The role of plasma exchange is also discussed.
Zitieren
APA
Adair, P., Musette, M. S., & Fakhry, A. (2025). Introduction. Maghreb - Machrek. https://doi.org/10.3917/e.machr.258.0005
Vancouver
Adair P, Musette MS, Fakhry A. Introduction. Maghreb - Machrek. 2025. doi:10.3917/e.machr.258.0005
BibTeX
@article{Adair2025,
author = {Adair, Philippe and Musette, Mohamed Saib and Fakhry, Alia},
title = {Introduction},
journal = {Maghreb - Machrek},
year = {2025},
doi = {10.3917/e.machr.258.0005}
}
EUVIMED